← Back
$SMMT All transactions

Summit Therapeutics Inc.

▲ BUY
8 / 10

Conviction

$ Value

$90K

Shares

5,000

Price

$18

Filed

Sep 11

Why this score? (8/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Zanganeh Mahkam

Title

Co-Chief Executive Officer

CIK

0001507650

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-09-11

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

556,093,090

Footnotes

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.49 to $17.89 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose

Filing Info

Accession No.

0001599298-25-000143

Form Type

4

Issuer CIK

0001599298

Zanganeh Mahkam's History

Date Ticker Type Value
2026-01-02 SMMT A $98K
2025-10-21 SMMT A $5.0M
2025-10-21 SMMT $500K
2025-10-21 SMMT A $262.0M
2025-09-11 SMMT $90K
2025-09-10 SMMT $5.9M
2025-08-15 PLSE A $0
2025-08-15 PLSE A $0
2025-05-30 SMMT M $197K
2025-05-30 SMMT M $0

Other Insiders at SMMT (90d)

No other insider activity at this issuer in the last 90 days.